GRML (Greenland Mines) ROE % Adjusted to Book Value: -34.51% (As of Mar. 2026)


GRML Greenland Mines Ltd GRML
12 GF Score
Price $0.25
! 1 Warning Sign
View Full Analysis

What is Greenland Mines ROE % Adjusted to Book Value?

Greenland Mines GRML +0.33% 12 ROE % Adjusted to Book Value is -34.51% as of Mar. 2026. GuruFocus rates GRML with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Greenland Mines's ROE % for the quarter that ended in Mar. 2026 was -26.92%. Greenland Mines's PB Ratio for the quarter that ended in Mar. 2026 was 0.78. Greenland Mines's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -34.51%.

Greenland Mines ROE % Adjusted to Book Value Related Terms

Greenland Mines ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Greenland Mines's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Greenland Mines ROE % Adjusted to Book Value Chart

Greenland Mines Annual Data
Trend
ROE % Adjusted to Book Value

Greenland Mines Semi-Annual Data
Mar25 Mar26
ROE % Adjusted to Book Value 0.00 -34.51

GRML vs SRGZ, RITE, DYNR: ROE % Adjusted to Book Value Comparison

For the Other Precious Metals & Mining subindustry, Greenland Mines's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Greenland Mines ROE % Adjusted to Book Value vs Metals & Mining Industry

For the Metals & Mining industry and Basic Materials sector, Greenland Mines's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Greenland Mines's ROE % Adjusted to Book Value falls into.


GRML
12GF Score
Greenland Mines Ltd GRML
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Greenland Mines ROE % Adjusted to Book Value Calculation

Greenland Mines's ROE % Adjusted to Book Value for the fiscal year that ended in . 20 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Greenland Mines's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-26.92% / 0.78
=-34.51%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -34.51% mean?
Greenland Mines (GRML) has a ROE % Adjusted to Book Value of -34.51% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Greenland Mines and its competitors.
Is Greenland Mines' ROE % Adjusted to Book Value too high?
Greenland Mines' current ROE % Adjusted to Book Value is -34.51%. Overall, Greenland Mines has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Greenland Mines' ROE % Adjusted to Book Value compare to SRGZ and RITE?
Greenland Mines' ROE % Adjusted to Book Value of -34.51% can be compared against companies in the Metals & Mining industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Metals & Mining company?
A good ROE % Adjusted to Book Value depends on the Metals & Mining industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Greenland Mines and its competitors. Greenland Mines's current ROE % Adjusted to Book Value is -34.51%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Greenland Mines stock overvalued right now?
Greenland Mines (GRML) has a current ROE % Adjusted to Book Value of -34.51%. The current ROE % Adjusted to Book Value is -34.51%. Greenland Mines' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Greenland Mines (GRML), the current ROE % Adjusted to Book Value is -34.51% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Greenland Mines Business Description

Address 1300 South Boulevard, Unit D, Charlotte, NC, USA, 28203
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.
12GF Score

Get the complete analysis for GRML

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.25
Price